SAT-398 LOW DOSE OF RITUXIMAB IS CLINICALLY AND COST...

Kidney International Reports 2020 / 03 Vol. 5; Iss. 3

SAT-398 LOW DOSE OF RITUXIMAB IS CLINICALLY AND COST EFFECTIVE IN PRIMARY MEMBRANOUS NEPHROPATHY

George, J., Alex, S., Raji, R., George, M., Gopal, A., Thomas, A., Gracious, N.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Journal:
Kidney International Reports
DOI:
10.1016/j.ekir.2020.02.422
Date:
March, 2020
File:
PDF, 210 KB
2020
Conversion to is in progress
Conversion to is failed